Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Recruiting · NCT04691622 · Registry updated 2026-01-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infections, Primary Immunodeficiency Diseases, hereditary disease, immune system disorder, inborn error of immunity, viral infectious disease | Recruiting | Phase 1 | 2026-01-26 | NCT04691622 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Children's National Research Institute | 84 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's National Hospital | Washington D.C. | United States | 100 |
| Johns Hopkins University | Baltimore | United States | 150 |
| National Institutes of Health (NIH) | Bethesda | United States | 4 |